Increasing electronic health literacy: A three-pronged approach
Use assessment, education, and support to create informed healthcare consumers. By Meigan Robb, PhD, RN, and Teresa Shellenbarger, PhD, RN, CNE, ANEF Takeaways: Changes in…
Web Exclusives
July ANA on the Frontline
Learn about the top issues facing ANA member nurses, how ANA is working for you, and what ANA is doing to advance nursing. In…
Biological clocks in digestive organs may be reason for metabolism disruption with shift work
Biological clocks (peripheral oscillators) in the liver, gut, and pancreas may be the reason for disruption of metabolism in people who work night shifts,…
High insurance denial rates for breakthrough hepatitis drugs
Insurance denial rates for direct-acting antiviral drugs used to treat hepatitis C are high—more than 50% for those with private insurance—according to a study…
FDA approves first biosimilar to Neulasta
On June 4, the U.S. Food and Drug Administration (FDA)Â approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of…
Clinical trial participants’ views on data sharing
Most participants in clinical trials believe the benefits of broadly sharing person-level data outweigh the risks, according to a study in The New England…
The clinical opiate withdrawal protocol in an acute-care setting
How one hospital is taking a stand against the opioid epidemic. Takeaways: Limited resources for the treatment of patients experiencing opioid withdrawal often results…
Using aromatherapy in the clinical setting: Making sense of scents
Aromatherapy is an age-old therapy designed to alter mood and physical symptoms. It has gained popularity as a safe and cost-effective complementary and alternative…
June ANA on the Frontline: 2017 Annual Report
Learn about the top issues facing ANA member nurses, how ANA is working for you, and what ANA is doing to advance nursing.
June 2018 Vol. 13 No. 6
Click here to access the digital edition When you take care of yourself, you’re better able to take care of your patients and their…
Dopamine and family history of alcohol use disorder
People with a family history of alcohol use disorder (AUD) release more dopamine in the brain’s main reward center in response to the expectation…
FDA approves new drug for thrombocytopenia in patients with chronic liver disease
On May 21, the U.S. Food and Drug Administration (FDA) approved approved Doptelet (avatrombopag) tablets to treat thrombocytopenia in adults with chronic liver disease…
Increasing electronic health literacy: A three-pronged approach
Use assessment, education, and support to create informed healthcare consumers. By Meigan Robb, PhD, RN, and Teresa Shellenbarger, PhD, RN, CNE, ANEF Takeaways:…
July ANA on the Frontline
Learn about the top issues facing ANA member nurses, how ANA is working for you, and what ANA is doing to advance…
Biological clocks in digestive organs may be reason for metabolism disruption with shift work
Biological clocks (peripheral oscillators) in the liver, gut, and pancreas may be the reason for disruption of metabolism in people who work…
High insurance denial rates for breakthrough hepatitis drugs
Insurance denial rates for direct-acting antiviral drugs used to treat hepatitis C are high—more than 50% for those with private insurance—according to…
FDA approves first biosimilar to Neulasta
On June 4, the U.S. Food and Drug Administration (FDA)Â approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the…
Clinical trial participants’ views on data sharing
Most participants in clinical trials believe the benefits of broadly sharing person-level data outweigh the risks, according to a study in The…
The clinical opiate withdrawal protocol in an acute-care setting
How one hospital is taking a stand against the opioid epidemic. Takeaways: Limited resources for the treatment of patients experiencing opioid withdrawal…
Using aromatherapy in the clinical setting: Making sense of scents
Aromatherapy is an age-old therapy designed to alter mood and physical symptoms. It has gained popularity as a safe and cost-effective complementary…
June ANA on the Frontline: 2017 Annual Report
Learn about the top issues facing ANA member nurses, how ANA is working for you, and what ANA is doing to advance…
June 2018 Vol. 13 No. 6
Click here to access the digital edition When you take care of yourself, you’re better able to take care of your patients…
Dopamine and family history of alcohol use disorder
People with a family history of alcohol use disorder (AUD) release more dopamine in the brain’s main reward center in response to…
FDA approves new drug for thrombocytopenia in patients with chronic liver disease
On May 21, the U.S. Food and Drug Administration (FDA) approved approved Doptelet (avatrombopag) tablets to treat thrombocytopenia in adults with chronic…
Test Your Knowledge
Cannabis TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.